Discovery & Development

David Donabedian of Axial Biotherapuetics explains the role of the microbiome in the onset of Parkinson's Disease and autism.

It's time to rewrite the narrative about Africa's role in the pharmaceutical industry.

Oncology research has come a long way over the past 30 years, but we must transform outdated practices to further improve drug discovery innovation.

How is the changing landscape of microbiome R&D shaping conversations with regulators?

Researchers at the University of Bath have developed a technique which could prevent drugs from spoiling.

Male animal bias in preclinical research isn’t scientifically justified and may be skewing our understanding of the brain.

A new vaccine could help give people at risk of HIV more options.

Innovation in the ENT space is lacking. Lyra Therapeutics is, therefore, trying to create solutions for patient with unmet clinical needs.

"Let's adopt a lifecycle management approach to method development to ensure continued excellence."

Sitting Down With… Joan Mannick, Co-Founder and Chief Medical Officer at resTORbio, Massachusetts, USA.